{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:22:43Z","timestamp":1787836963149,"version":"build-2784847793"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pitt\u2013Hopkins syndrome (PTHS) is a rare neurodevelopmental disorder with pronounced impacts on physical health and everyday functioning, including severe intellectual disability, impaired communication, epilepsy, and breathing dysregulation. Despite significant clinical challenges, there is limited evidence to guide interventions for individuals with PTHS. This scoping review aimed to examine the available literature on interventions targeting challenges experienced by individuals with PTHS and to identify gaps in the current knowledge base.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixteen peer-reviewed publications, published between 2012 and 2024, met the inclusion criteria. The majority of studies focused on medical management, predominantly addressing epilepsy and breathing abnormalities, and were pharmacological in nature. Most studies employed case report or small case series designs, and systematic outcome measurement approaches were rare. Epilepsy interventions largely reflected clinical practices in broader epilepsy populations, with common use of conventional antiseizure medications and evidence of potential benefit from newer agents in treatment-resistant cases. Non-pharmacological treatments, including vagus nerve stimulation, corpus callosotomy, ketogenic diet, and a walking-based mobility intervention, were described in only a few studies, with heterogeneous outcomes. Interventions for respiratory dysfunction, gastrointestinal symptoms, pain management, immune dysfunction, psychiatric or behavioral difficulties were limited and typically reported in individual cases. Research addressing psychosocial, behavioral, and participation-focused interventions was notably scarce, despite the broad functional impairments associated with PTHS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This scoping review shows that intervention research in PTHS remains at an early stage, with an evidence base dominated by descriptive case studies and few systematic evaluations. This limits the ability to formulate robust, evidence-based treatment recommendations. There is a need for more rigorous research designs in future research, that enable causal inference and systematic outcome measurement. Moreover, future studies should broaden the scope of intervention research to include communication, behavior, participation, physical activity and quality of life, alongside medical management, to better support the complex needs of individuals with PTHS. Increased focus on family impact and long-term outcomes may further enhance understanding and care strategies for this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04561-6","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:04:06Z","timestamp":1787828646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interventions targeting challenges experienced by individuals with Pitt Hopkins syndrome: a scoping review"],"prefix":"10.1186","volume":"21","author":[{"given":"Monika","family":"Dolik-Michno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Starbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Wandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika Jernberg","family":"Gr\u00f6nlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Gustavsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-5546","authenticated-orcid":false,"given":"Linn","family":"Johnels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"4","key":"4561_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/cge.13506","volume":"95","author":"M Zollino","year":"2019","unstructured":"Zollino M, Zweier C, Van Balkom ID, Sweetser DA, Alaimo J, Bijlsma EK, et al. Diagnosis and management in Pitt-Hopkins syndrome: First international consensus statement. Clin Genet. 2019;95(4):462\u201378.","journal-title":"Clin Genet"},{"issue":"1","key":"4561_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/humu.21639","volume":"33","author":"S Whalen","year":"2012","unstructured":"Whalen S, H\u00e9ron D, Gaillon T, Moldovan O, Rossi M, Devillard F, et al. Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum. Hum Mutat. 2012;33(1):64\u201372.","journal-title":"Hum Mutat"},{"issue":"3\u20135","key":"4561_CR3","first-page":"171","volume":"2","author":"M Peippo","year":"2012","unstructured":"Peippo M, Ignatius J. Pitt-Hopkins syndrome. Mol Syndromol. 2012;2(3\u20135):171\u201380.","journal-title":"Mol Syndromol"},{"issue":"5","key":"4561_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1684\/epd.2020.1212","volume":"22","author":"H Yamada","year":"2020","unstructured":"Yamada H, Tamasaki A, Oguri M, Hori I, Saitoh S, Maegaki Y. Frequent epileptic apnoea in a patient with Pitt-Hopkins syndrome. Epileptic Disord. 2020;22(5):673\u20137.","journal-title":"Epileptic Disord"},{"issue":"1","key":"4561_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ene.15104","volume":"29","author":"S Matricardi","year":"2022","unstructured":"Matricardi S, Bonanni P, Iapadre G, Elia M, Cesaroni E, Danieli A, et al. Epilepsy, electroclinical features, and long-term outcomes in Pitt-Hopkins syndrome due to pathogenic variants in the TCF4 gene. Eur J Neurol. 2022;29(1):19\u201325.","journal-title":"Eur J Neurol"},{"issue":"1","key":"4561_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13023-016-0422-2","volume":"11","author":"CF de Winter","year":"2016","unstructured":"de Winter CF, Baas M, Bijlsma EK, van Heukelingen J, Routledge S, Hennekam RC. Phenotype and natural history in 101 individuals with Pitt-Hopkins syndrome through an internet questionnaire system. Orphanet J Rare Dis. 2016;11(1):37.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"4561_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1055\/s-0035-1564570","volume":"4","author":"G Marangi","year":"2015","unstructured":"Marangi G, Zollino M. Pitt-Hopkins syndrome and differential diagnosis: a molecular and clinical challenge. J Pediatr Genet. 2015;4(3):168\u201376.","journal-title":"J Pediatr Genet"},{"issue":"1","key":"4561_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s11689-019-9282-0","volume":"11","author":"A Watkins","year":"2019","unstructured":"Watkins A, Bissell S, Moss J, Oliver C, Clayton-Smith J, Haye L, et al. Behavioural and psychological characteristics in Pitt-Hopkins syndrome: a comparison with Angelman and Cornelia de Lange syndromes. J Neurodev Disord. 2019;11(1):24.","journal-title":"J Neurodev Disord"},{"issue":"9","key":"4561_CR9","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3390\/jcm13092605","volume":"13","author":"M Telenga","year":"2024","unstructured":"Telenga M, Rozensztrauch A, Gi\u017cewska-Kacprzak K, \u015amigiel R. From genotype to phenotype of Polish patients with Pitt-Hopkins syndrome concerning the quality of life and family functioning. J Clin Med. 2024;13(9):2605.","journal-title":"J Clin Med"},{"key":"4561_CR10","unstructured":"ERN-ITHAKA Clinical Guidelines Workgroup. Guidelines & consensus (WG11) [Internet]. Paris: ERN-ITHAKA. 2025 [cited 2025 Dec 21]. Available from: https:\/\/ern-ithaca.eu\/our-workgroups\/guidelines-consensus\/."},{"key":"4561_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"7","key":"4561_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"4561_CR13","volume-title":"JBI Manual for Evidence Synthesis","author":"S Moola","year":"2020","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Systematic reviews of etiology and risk. In: Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. Adelaide: JBI; 2020. Available at: https:\/\/synthesismanual.jbi.global."},{"issue":"10","key":"4561_CR14","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Database Syst Rev Implement Rep. 2020;18(10):2127\u201333.","journal-title":"JBI Database Syst Rev Implement Rep"},{"issue":"4","key":"4561_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1037\/1040-3590.6.4.284","volume":"6","author":"DV Cicchetti","year":"1994","unstructured":"Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6(4):284\u201390.","journal-title":"Psychol Assess"},{"issue":"1","key":"4561_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/17483107.2016.1278469","volume":"13","author":"AF Casey","year":"2018","unstructured":"Casey AF, Pickard V, Ullrich C, MacNeil Z. An adapted walking intervention for a child with Pitt-Hopkins syndrome. Disabil Rehabil Assist Technol. 2018;13(1):25\u201330.","journal-title":"Disabil Rehabil Assist Technol"},{"issue":"3","key":"4561_CR17","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1097\/YCT.0000000000000778","volume":"37","author":"TLP Vieira","year":"2021","unstructured":"Vieira TLP, Schlittler LX, Vieira LC, Celeri EH, Banzato CE. Effective electroconvulsive therapy for catatonia in a patient with Pitt-Hopkins syndrome and autism spectrum disorder. J ECT. 2021;37(3):e33\u20134.","journal-title":"J ECT"},{"key":"4561_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijdevneu.2018.03.010","volume":"67","author":"Y Liu","year":"2018","unstructured":"Liu Y, Guo Y, Liu P, Li F, Yang C, Song J, et al. A case of Pitt-Hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy. Int J Dev Neurosci. 2018;67:51\u20134.","journal-title":"Int J Dev Neurosci"},{"issue":"2","key":"4561_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.braindev.2021.09.003","volume":"44","author":"H Kirikae","year":"2022","unstructured":"Kirikae H, Uematsu M, Numata-Uematsu Y, Saijo N, Katata Y, Oikawa Y, et al. Two types of early epileptic encephalopathy in a Pitt-Hopkins syndrome patient with a novel TCF4 mutation. Brain Dev. 2022;44(2):148\u201352.","journal-title":"Brain Dev"},{"issue":"1","key":"4561_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-024-03055-7","volume":"19","author":"T Zhao","year":"2024","unstructured":"Zhao T, Wu S, Shen Y, Leng J, Genchev GZ, Lu H, et al. Clinical and genetic characterization of 47 Chinese pediatric patients with Pitt-Hopkins syndrome: a retrospective study. Orphanet J Rare Dis. 2024;19(1):51.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"4561_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1684\/epd.2019.1103","volume":"21","author":"Y Calle-Lopez","year":"2019","unstructured":"Calle-Lopez Y, Kotagal P, Knight EP. Perampanel-induced hair curling in a patient with epilepsy associated with Pitt-Hopkins syndrome. Epileptic Disord. 2019;21(5):479\u201382.","journal-title":"Epileptic Disord"},{"issue":"12","key":"4561_CR22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1177\/0883073811435917","volume":"27","author":"I Maini","year":"2012","unstructured":"Maini I, Cantalupo G, Turco EC, Paolis FD, Magnani C, Parrino L, et al. Clinical and polygraphic improvement of breathing abnormalities after valproate in a case of Pitt-Hopkins syndrome. J Child Neurol. 2012;27(12):1585\u20138.","journal-title":"J Child Neurol"},{"issue":"4","key":"4561_CR23","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/ajmg.a.35247","volume":"158","author":"SL Verhulst","year":"2012","unstructured":"Verhulst SL, De Dooy J, Ramet J, Bockaert N, Van Coster R, Ceulemans B, et al. Acetazolamide for severe apnea in Pitt-Hopkins syndrome. Am J Med Genet A. 2012;158(4):932\u20134.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"4561_CR24","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/ajmg.a.37034","volume":"167","author":"C Gaffney","year":"2015","unstructured":"Gaffney C, McNally P. Successful use of acetazolamide for central apnea in a child with Pitt-Hopkins syndrome. Am J Med Genet A. 2015;167(6):1423\u20134.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"4561_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/13554794.2024.2348230","volume":"29","author":"C Istanbullu","year":"2023","unstructured":"Istanbullu C, Kayan Ocakoglu B, Karacetin G. A case of Pitt-Hopkins syndrome: psychopharmacological approach for anxiety, insomnia, and agitation. Neurocase. 2023;29(4):117\u201320.","journal-title":"Neurocase"},{"issue":"3","key":"4561_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/JCP.0000000000000871","volume":"38","author":"S Lambrechts","year":"2018","unstructured":"Lambrechts S, Devriendt K, Vogels A. Low-dose aripiprazole and risperidone for treating problem behavior in children with Pitt-Hopkins syndrome. J Clin Psychopharmacol. 2018;38(3):260\u20131.","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"4561_CR27","doi-asserted-by":"publisher","first-page":"e63490","DOI":"10.1002\/ajmg.a.63490","volume":"194","author":"S Malik","year":"2024","unstructured":"Malik S, Jeanpierre L, Cianferoni A, Ruffner M, Sullivan KE. A patient with Pitt-Hopkins syndrome with concomitant common variable immunodeficiency. Am J Med Genet A. 2024;194(4):e63490.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"4561_CR28","doi-asserted-by":"publisher","first-page":"e258257","DOI":"10.1136\/bcr-2023-258257","volume":"17","author":"L Reaney","year":"2024","unstructured":"Reaney L, Collins A. Complex visceral hyperalgesia in an adolescent with Pitt-Hopkins syndrome. BMJ Case Rep. 2024;17(2):e258257.","journal-title":"BMJ Case Rep"},{"key":"4561_CR29","unstructured":"Firefly (Leckey). Upsee mobility device [Internet]. Belfast (UK): Leckey; 2025 [cited 2025 Dec 21]. Available from: https:\/\/www.leckey.com\/products\/firefly-upsee."},{"key":"4561_CR30","doi-asserted-by":"publisher","DOI":"10.4324\/9781315801933","volume-title":"Goal attainment scaling: Applications, theory, and measurement","author":"TJ Kiresuk","year":"2014","unstructured":"Kiresuk TJ, Smith A, Cardillo JE. Goal attainment scaling: Applications, theory, and measurement. New York: Psychology; 2014."},{"key":"4561_CR31","doi-asserted-by":"publisher","first-page":"108383","DOI":"10.1016\/j.yebeh.2021.108383","volume":"125","author":"J Goldstein","year":"2021","unstructured":"Goldstein J, Kwon C-S, Harmon M, Buchhalter J, Kukla A, McCallum S, et al. Seizure documentation in people living with epilepsy. Epilepsy Behav. 2021;125:108383.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"4561_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/15402002.2016.1173556","volume":"16","author":"KH Maich","year":"2018","unstructured":"Maich KH, Lachowski AM, Carney CE. Psychometric properties of the consensus sleep diary in those with insomnia disorder. Behav Sleep Med. 2018;16(2):117\u201334.","journal-title":"Behav Sleep Med"},{"issue":"2","key":"4561_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s13760-018-1045-2","volume":"120","author":"V Sulentic","year":"2020","unstructured":"Sulentic V, Petelin Gadze Z, Dapic Ivancic B, Mrak G, Borovecki F. Overlap of the Pitt-Hopkins and Lennox-Gastaut syndromes. Acta Neurol Belg. 2020;120(2):399\u2013401.","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"4561_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/14656566.2020.1865311","volume":"22","author":"F Brigo","year":"2021","unstructured":"Brigo F, Lattanzi S. Pharmacotherapeutic considerations for late-onset epilepsy. Expert Opin Pharmacother. 2021;22(4):389\u201391.","journal-title":"Expert Opin Pharmacother"},{"key":"4561_CR35","doi-asserted-by":"publisher","first-page":"674483","DOI":"10.3389\/fneur.2021.674483","volume":"12","author":"A Fattorusso","year":"2021","unstructured":"Fattorusso A, Matricardi S, Mencaroni E, Dell\u2019Isola GB, Di Cara G, Striano P, et al. The pharmacoresistant epilepsy: an overview on existent and new emerging therapies. Front Neurol. 2021;12:674483.","journal-title":"Front Neurol"},{"issue":"1","key":"4561_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14581\/jer.19002","volume":"9","author":"KM Park","year":"2019","unstructured":"Park KM, Kim SE, Lee BI. Antiepileptic drug therapy in patients with drug-resistant epilepsy. J Epilepsy Res. 2019;9(1):14\u201320.","journal-title":"J Epilepsy Res"},{"key":"4561_CR37","doi-asserted-by":"publisher","first-page":"610379","DOI":"10.3389\/fneur.2020.610379","volume":"11","author":"B Fisher","year":"2021","unstructured":"Fisher B, DesMarteau JA, Koontz EH, Wilks SJ, Melamed SE. Responsive vagus nerve stimulation for drug resistant epilepsy: a review of new features and practical guidance for advanced practice providers. Front Neurol. 2021;11:610379.","journal-title":"Front Neurol"},{"issue":"2","key":"4561_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/epi.17152","volume":"63","author":"KH Kostov","year":"2022","unstructured":"Kostov KH, Kostov H, Larsson PG, Henning O, Eckmann CAC, Lossius MI, et al. Norwegian population-based study of long-term effects, safety, and predictors of response of vagus nerve stimulation treatment in drug-resistant epilepsy: The NORPulse study. Epilepsia. 2022;63(2):414\u201325.","journal-title":"Epilepsia"},{"key":"4561_CR39","doi-asserted-by":"publisher","unstructured":"Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2020;(6):CD001903. https:\/\/doi.org\/10.1002\/14651858.CD001903.pub5.","DOI":"10.1002\/14651858.CD001903.pub5"},{"key":"4561_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.seizure.2024.11.001","volume":"123","author":"R Whitney","year":"2024","unstructured":"Whitney R, Otsubo H, Cunningham J, Jones KC, RamachandranNair R, Nouri MN, et al. Corpus callosotomy for refractory epileptic spasms: Systematic review and meta-analysis. Seizure. 2024;123:159\u201367.","journal-title":"Seizure"},{"key":"4561_CR41","doi-asserted-by":"publisher","first-page":"832877","DOI":"10.3389\/fped.2022.832877","volume":"10","author":"IJ Koppen","year":"2022","unstructured":"Koppen IJ, Benninga MA. Functional constipation and dyssynergic defecation in children. Front Pediatr. 2022;10:832877.","journal-title":"Front Pediatr"},{"issue":"6","key":"4561_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/WNF.0000000000000412","volume":"43","author":"SA Hamed","year":"2020","unstructured":"Hamed SA, Tohamy AM, Mohamed KO. The effect of epilepsy and antiepileptic drugs on cortical motor excitability in patients with temporal lobe epilepsy. Clin Neuropharmacol. 2020;43(6):175\u201384.","journal-title":"Clin Neuropharmacol"},{"issue":"9","key":"4561_CR43","first-page":"923","volume":"42","author":"B Anil","year":"2005","unstructured":"Anil B, Nedunchezian K, Jayanthini V, Pathmanabhan M. Breath holding spells: evaluation of autonomic nervous system function. Indian Pediatr. 2005;42(9):923\u20136.","journal-title":"Indian Pediatr"},{"issue":"4","key":"4561_CR44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1055\/s-0033-1363093","volume":"45","author":"H Arslan","year":"2014","unstructured":"Arslan H, Torun E, Akkan JCU, Guler S, Bayraktar S. The evaluation of physiological and biochemical parameters and the autonomic nervous systems of children with breath-holding spells. Neuropediatr. 2014;45(4):212\u20136.","journal-title":"Neuropediatr"},{"issue":"4","key":"4561_CR45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/0887-8994(93)90062-H","volume":"9","author":"FJ DiMario Jr","year":"1993","unstructured":"DiMario FJ Jr, Burleson JA. Autonomic nervous system function in severe breath-holding spells. Pediatr Neurol. 1993;9(4):268\u201374.","journal-title":"Pediatr Neurol"},{"key":"4561_CR46","first-page":"479364","volume":"2010","author":"S Chateauvieux","year":"2010","unstructured":"Chateauvieux S, Morceau F, Dicato M, Diederich M. Molecular and therapeutic potential and toxicity of valproic acid. Biomed Res Int. 2010;2010:479364.","journal-title":"Biomed Res Int"},{"issue":"1","key":"4561_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1874467210902010095","volume":"2","author":"B Monti","year":"2009","unstructured":"Monti B, Polazzi E, Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol. 2009;2(1):95\u2013109.","journal-title":"Curr Mol Pharmacol"},{"issue":"4","key":"4561_CR48","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1152\/japplphysiol.01572.2005","volume":"102","author":"DE Leaf","year":"2007","unstructured":"Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol. 2007;102(4):1313\u201322.","journal-title":"J Appl Physiol"},{"issue":"1","key":"4561_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1753465816677006","volume":"11","author":"HM Liu","year":"2017","unstructured":"Liu HM, Chiang IJ, Kuo KN, Liou CM, Chen C. The effect of acetazolamide on sleep apnea at high altitude: a systematic review and meta-analysis. Ther Adv Respir Dis. 2017;11(1):20\u20139.","journal-title":"Ther Adv Respir Dis"},{"issue":"3","key":"4561_CR50","first-page":"230","volume":"20","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Tai JE, Yee BJ. Management of central sleep apnoea: a review of non-hypercapnic causes. Breathe (Sheff). 2024;20(3):230\u20138.","journal-title":"Breathe (Sheff)"},{"issue":"11","key":"4561_CR51","doi-asserted-by":"publisher","first-page":"E242","DOI":"10.1002\/humu.20859","volume":"29","author":"I Giurgea","year":"2008","unstructured":"Giurgea I, Missirian C, Cacciagli P, Whalen S, Fredriksen T, Gaillon T, et al. TCF4 deletions in Pitt-Hopkins syndrome. Hum Mutat. 2008;29(11):E242\u201351.","journal-title":"Hum Mutat"},{"issue":"5","key":"4561_CR52","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1086\/515582","volume":"80","author":"J Amiel","year":"2007","unstructured":"Amiel J, Rio M, De Pontual L, Redon R, Malan V, Boddaert N, et al. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet. 2007;80(5):988\u201393.","journal-title":"Am J Hum Genet"},{"key":"4561_CR53","unstructured":"Sweetser DA, Gipson KS, Zar-Kessler C. Pitt-Hopkins syndrome. GeneReviews [Internet]. Seattle (WA): University of Washington; 2025 [cited 2025 Dec 21]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK100240\/."},{"issue":"3","key":"4561_CR54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0883073817750490","volume":"33","author":"K Goodspeed","year":"2018","unstructured":"Goodspeed K, Newsom C, Morris MA, Powell C, Evans P, Golla S. Pitt-Hopkins syndrome: a review of current literature, clinical approach, and 23-patient case series. J Child Neurol. 2018;33(3):233\u201344.","journal-title":"J Child Neurol"},{"key":"4561_CR55","doi-asserted-by":"publisher","first-page":"110187","DOI":"10.1016\/j.pnpbp.2020.110187","volume":"108","author":"AN Ligezka","year":"2021","unstructured":"Ligezka AN, Sonmez AI, Corral-Frias MP, Golebiowski R, Lynch B, Croarkin PE, et al. A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2021;108:110187.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4561_CR56","doi-asserted-by":"publisher","unstructured":"Gan Y, Chen Y, Zhong H, Liu Z, Geng J, Wang H, et al. Gut microbes in central nervous system development and related disorders. https:\/\/doi.org\/10.3389\/fimmu.2023.1288256","DOI":"10.3389\/fimmu.2023.1288256"},{"key":"4561_CR57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-clinpsy-050718-095432","volume":"15","author":"MI Butler","year":"2019","unstructured":"Butler MI, Cryan JF, Dinan TG. Man and the microbiome: a new theory of everything? Annu Rev Clin Psychol. 2019;15:371\u201398.","journal-title":"Annu Rev Clin Psychol"},{"key":"4561_CR58","doi-asserted-by":"publisher","first-page":"205873842110394","DOI":"10.1177\/20587384211039400","volume":"35","author":"A Hogendorf","year":"2021","unstructured":"Hogendorf A, Szadkowska A, Michalak A, Surman M, Trojan-Borczynska K, M\u0142ynarski W, et al. Subcutaneous immunoglobulin replacement therapy in a patient with 18q deletion syndrome, primary immune deficiency, and type 1 diabetes. Int J Immunopathol Pharmacol. 2021;35:20587384211039400.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"4561_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4278\/ajhp.070930103","volume":"23","author":"CC Johnson","year":"2009","unstructured":"Johnson CC. The benefits of physical activity for youth with developmental disabilities: a systematic review. Am J Health Promot. 2009;23(3):157\u201367.","journal-title":"Am J Health Promot"},{"key":"4561_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brat.2018.11.015","volume":"117","author":"AE Kazdin","year":"2019","unstructured":"Kazdin AE. Single-case experimental designs. Evaluating interventions in research and clinical practice. Behav Res Ther. 2019;117:3\u201317.","journal-title":"Behav Res Ther"},{"issue":"3\u20134","key":"4561_CR61","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/09602011.2013.875043","volume":"24","author":"RL Tate","year":"2014","unstructured":"Tate RL, Perdices M, McDonald S, Togher L, Rosenkoetter U. The design, conduct and report of single-case research: Resources to improve the quality of the neurorehabilitation literature. Neuropsychol Rehabil. 2014;24(3\u20134):315\u201331.","journal-title":"Neuropsychol Rehabil"},{"key":"4561_CR62","volume-title":"Applied behavior analysis","author":"JO Cooper","year":"2020","unstructured":"Cooper JO, Heron TE, Heward WL. Applied behavior analysis. 3rd ed. Hoboken (NJ): Pearson; 2020.","edition":"3"},{"issue":"1","key":"4561_CR63","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12903-024-04296-5","volume":"24","author":"Y Hassona","year":"2024","unstructured":"Hassona Y, Alqaisi DA, Alkilani A, AbuHijleh I. Expanding the phenotype in Pitt-Hopkins syndrome; description of new oral finding and dental management considerations. BMC Oral Health. 2024;24(1):597.","journal-title":"BMC Oral Health"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04561-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:03:17Z","timestamp":1787835797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04561-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4561"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04561-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"300"}}